Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
4.
S D Med ; Spec no: 123-6, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23444603

RESUMO

Vaccines are one of the greatest public health achievements and have had a tremendous impact on people's health and survival around the world. Nevertheless, highly prevalent infectious disease threats unresponsive to traditional immunization strategies, emerging and re-emerging threats, and non-communicable diseases amenable to immunization remain critical global health challenges. Scientific advances will reveal solutions, but it will take political, social and economic commitment from all stakeholders for these solutions to achieve their health protection benefit among the people who need them most.


Assuntos
Saúde Pública , Vacinação/métodos , Vacinas/farmacologia , Doenças Transmissíveis/epidemiologia , Saúde Global , Humanos
5.
Infect Control Hosp Epidemiol ; 31 Suppl 1: S73-5, 2010 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-20929378

RESUMO

Healthcare epidemiology is a robust and adaptable profession with the noble mission of protecting patients and their healthcare providers from infectious diseases and other threats. Change is the constant that links the successes of our field in each decade of our history. Although it is not possible to predict what specific challenges the next decade will bring, the themes of the Sixth Decennial International Conference in 2020 are likely to reflect the most prominent drivers of change that are affecting our profession, including globalization, sustainability, and consumer empowerment.


Assuntos
Atenção à Saúde , Epidemiologia/história , Doenças Transmissíveis , História do Século XX , História do Século XXI , Humanos , Controle de Infecções
10.
Curr HIV/AIDS Rep ; 1(4): 159-65, 2004 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16091237

RESUMO

The principles of managing patients with recent HIV exposures are similar whether the exposure occurs in an occupational or nonoccupational setting. For both settings, clinicians should 1) assess the likelihood that HIV and other bloodborne viruses will be transmitted as a consequence of the exposure; 2) advise the patient about the risks and benefits of treatment; 3) choose an appropriate antiretroviral treatment regimen (if the decision is made to treat); 4) screen for other illnesses that may complicate treatment or follow-up; 5) counsel patients about the importance of adhering to treatment; 6) promote safe-sex practices and methods to avoid future exposures; 7) follow the patient for potential side effects of treatment; 8) provide follow-up care including repeat HIV testing for seroconversion, surveillance for primary HIV infection, and reinforcement of counseling messages.


Assuntos
Fármacos Anti-HIV/uso terapêutico , Aconselhamento , Infecções por HIV , Exposição Ocupacional/efeitos adversos , Comportamento Sexual , Fármacos Anti-HIV/efeitos adversos , Feminino , Infecções por HIV/tratamento farmacológico , Infecções por HIV/etiologia , Infecções por HIV/transmissão , Humanos , Masculino , Ferimentos Penetrantes Produzidos por Agulha/complicações , Medição de Risco
11.
Science ; 300(5628): 2036-9, 2003 Jun 27.
Artigo em Inglês | MEDLINE | ID: mdl-12829768

RESUMO

A new collaborative model of research is needed to increase resources, to prioritize the R (ii) to increase the pace, reduce the overlap, and more systematically explore the elements of and delivery systems for vaccines; (iii) to use common standards for the prompt comparative testing of vaccine candidates; (iv) to expand resources for manufacturing vaccine candidates to speed their use in human trials; and (v) to increase the capacity for international clinical trials and to focus this effort toward quickly measuring the effectiveness of vaccine protection as prototype vaccine candidates are identified.


Assuntos
Vacinas contra a AIDS , Saúde Global , Infecções por HIV/prevenção & controle , HIV-1/imunologia , Política Pública , Vacinas contra a AIDS/administração & dosagem , Vacinas contra a AIDS/economia , Vacinas contra a AIDS/imunologia , Academias e Institutos/economia , Academias e Institutos/organização & administração , Biotecnologia/economia , Ensaios Clínicos como Assunto/normas , Desenho de Fármacos , Avaliação Pré-Clínica de Medicamentos/normas , Indústria Farmacêutica/economia , Apoio Financeiro , Humanos , Propriedade Intelectual , Cooperação Internacional , Estudos Multicêntricos como Assunto , Setor Privado , Setor Público , Apoio à Pesquisa como Assunto , Vacinação
14.
Curr Infect Dis Rep ; 4(6): 543-549, 2002 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-12433332

RESUMO

The principles of managing patients with recent HIV exposure are similar whether the exposure occurs in an occupational or nonoccupational setting. For both settings, clinicians should assess the likelihood that HIV and other bloodborne viruses will be transmitted as a consequence of the exposure; advise the patient about the risks and benefits of treatment; choose an appropriate antiretroviral treatment regimen (if the decision is made to treat); screen for other illnesses that may complicate treatment or follow-up; counsel patients about the importance of adhering to treatment; promote safe-sex practices and methods to avoid future exposures; follow the patient for potential side effects of treatment; and provide follow-up care including repeat HIV testing for seroconversion, surveillance for primary HIV infection, and reinforcement of counseling messages.

15.
Am J Infect Control ; 30(7): 400-6, 2002 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-12410216

RESUMO

BACKGROUND: We report our experience in a county hospital with the use of selective contact isolation for patients with vancomycin-resistant Enterococcus faecium (VREF). About 12% of patients with VREF are isolated for reasons such as draining wounds and uncontrolled diarrhea. METHODS: Passive surveillance identified all inpatients (181) from 1995 to 1999 with cultures positive for VREF. Data were collected via electronic databases and from prospectively maintained infection control records. Isolates were typed with use of pulsed-field gel electrophoresis. RESULTS: Nearly all patients (175/181) with VREF had been admitted at least 48 hours or had a history of previous hospitalization. Most patients (69%) had urine cultures positive for VREF without blood cultures positive for the organism. Only 12 of 127 (9.%) patients with complete data had VREF infection on the basis of receiving treatment and/or having more than 1 blood culture positive for VREF. After VREF became endemic, statistically significant increased prevalence was not detected via surveillance of clinical cultures nor sequential point-prevalence studies. Two major genotypes carrying vanB resistance genes were identified and persisted throughout the period studied. VREF persisted in individual patients up to 46 months. CONCLUSIONS: The number of VREF infections in this facility has been low, despite appreciable colonization, for an extended period during which selective isolation was used.


Assuntos
Enterococcus faecium/efeitos dos fármacos , Infecções por Bactérias Gram-Positivas/epidemiologia , Infecções por Bactérias Gram-Positivas/microbiologia , Controle de Infecções/métodos , Isolamento de Pacientes , Resistência a Vancomicina , Vancomicina/farmacologia , Adulto , Técnicas de Tipagem Bacteriana , Feminino , Genótipo , Hospitais , Humanos , Controle de Infecções/estatística & dados numéricos , Unidades de Terapia Intensiva , Masculino , Fatores de Risco , Fatores de Tempo
16.
Ann Intern Med ; 137(8): 665-70, 2002 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-12379067

RESUMO

Hospital-onset infections, particularly those involving the urinary tract, lung, and bloodstream, are common and costly and cause substantial morbidity. This article analyzes the case of a 78-year-old man with lung cancer who died after developing hospital-onset pneumonia and urinary catheter-related infection during hospitalization for elective removal of a cerebellar metastasis. The field of infection control could benefit by adopting several approaches advocated by patient safety adherents, such as root-cause analysis. For example, hospital-onset infections that are implicated as attributable causes of death should perhaps be reviewed by local infection control teams regardless of the institution's overall infection rates. The patient safety movement can also learn from the traditions of infection control and hospital epidemiology. Specifically, applying infection control-based practices to safety problems may enhance safety. Such practices include establishing clear definitions of adverse events, standardizing methods for detecting and reporting events, creating appropriate rate adjustments for case-mix differences, instituting evidence-based intervention programs, and relying on skilled professionals to promote ongoing improvements in care.


Assuntos
Infecção Hospitalar/etiologia , Pneumonia Bacteriana/etiologia , Infecções Urinárias/etiologia , Idoso , Carcinoma Pulmonar de Células não Pequenas/secundário , Carcinoma Pulmonar de Células não Pequenas/cirurgia , Neoplasias Cerebelares/secundário , Neoplasias Cerebelares/cirurgia , Infecção Hospitalar/tratamento farmacológico , Infecção Hospitalar/prevenção & controle , Evolução Fatal , Humanos , Controle de Infecções/métodos , Controle de Infecções/normas , Neoplasias Pulmonares/patologia , Masculino , Erros Médicos , Cuidados Paliativos , Pneumonia Bacteriana/tratamento farmacológico , Infecções por Pseudomonas/etiologia , Fatores de Risco , Fatores de Tempo , Cateterismo Urinário/efeitos adversos , Infecções Urinárias/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA